Clinical Oncology Next Generation Sequencing Report 2020-30: Covid 19 Impact and Recovery

 The Business Research Company published its Clinical Oncology Next Generation Sequencing Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Clinical Oncology Next Generation Sequencing market. The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.

The report covers the clinical oncology next generation sequencing market’s segments-

1) By Technology: Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termination Sequencing, Nano-Pore Sequencing

2) By Application: Screening, Companion Diagnostics, Other Diagnostics

3) By End User: Hospital Laboratories, Clinical Research Organizations, Diagnostic laboratories.

View Complete Report:

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report-2020-30-covid-19-growth-and-change

Clinical Oncology Next Generation Sequencing Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. The chapter also covers markets which have been positively affected by the pandemic.

The global clinical oncology next generation sequencing market is expected to decline from $447.28 billion in 2019 to $437.55 billion in 2020 at a compound annual growth rate (CAGR) of -2.18%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $660.87 million in 2023 at a CAGR of 14.74%.

Companies in the clinical oncology next generation sequencing are increasingly investing in automation of workflow to increase precision and reduce the sample-to-sample variability.

Few Points From Table Of Content  

1. Executive Summary
2. Clinical Oncology Next Generation Sequencing Market Characteristics

3. Clinical Oncology Next Generation Sequencing Market Size And Growth

4. Clinical Oncology Next Generation Sequencing Market Segmentation
5. Clinical Oncology Next Generation Sequencing Market Regional And Country Analysis
……
25. Clinical Oncology Next Generation Sequencing Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Clinical Oncology Next Generation Sequencing Market

27. Clinical Oncology Next Generation Sequencing Market Trends And Strategies

28. Clinical Oncology Next Generation Sequencing Market Future Outlook and Potential Analysis

29. Appendix

Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=3344&type=smp

 

Few Points From List Of Table 
Table 1: Global Historic Market Growth, 2015-2019, $ Billion

Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Table 3: Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Technology, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Table 4: Global Clinical Oncology Next Generation Sequencing Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Table 5: Global Clinical Oncology Next Generation Sequencing Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
…….. 
Table 46: Thermo Fisher Scientific(Qiagen) Financial Performance

Table 47: Oxford Nanopore Technologies Financial Performance

Table 48: QIAGEN Financial Performance

Table 49: Myriad Genetics Financial Performance

Table 50: Illumina Financial Performance

About The Business Research Company: 
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.  
 

Contact Information: 
The Business Research Company 
Europe: +44 207 1930 708 
Asia: +91 8897263534 
Americas: +1 315 623 0293 
Email: info@tbrc.info